Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Heaton

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Science Advances|June 1, 2019
Control of antiviral innate immune response by protein geranylgeranylationShigao Yang, Alfred T Harding, Catherine Sweeney, et al.
Acta Biomaterialia|November 20, 2025
Presentation of hemagglutinin on adjuvant-bearing self-assembling peptide nanofibers increases heterologous responses against influenzaEmily F Roe, Nicole L Votaw, Kat M Lazar, et al.
Cell Genomics|December 5, 2022
Single-cell genome-wide association reveals that a nonsynonymous variant in <i>ERAP1</i> confers increased susceptibility to influenza virusBenjamin H Schott, Liuyang Wang, Xinyu Zhu, et al.
Plos Pathogens|July 5, 2024
mRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNALorena C S Chaves, Nichole Orr-Burks, Daryll Vanover, et al.
Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Immunity|January 21, 2016
Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus InfectionNicholas S Heaton, Natasha Moshkina, Romain Fenouil, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Stem Cell Reports|August 19, 2022
Rapid tissue prototyping with micro-organospheresZhaohui Wang, Matteo Boretto, Rosemary Millen, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
An integrated workflow for structural virology with a 100 keV electron microscopeRasangi Pathirage, Moumita Dutta, Ruth J Parsons, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Science Advances|June 1, 2019
Control of antiviral innate immune response by protein geranylgeranylationShigao Yang, Alfred T Harding, Catherine Sweeney, et al.
Acta Biomaterialia|November 20, 2025
Presentation of hemagglutinin on adjuvant-bearing self-assembling peptide nanofibers increases heterologous responses against influenzaEmily F Roe, Nicole L Votaw, Kat M Lazar, et al.
Cell Genomics|December 5, 2022
Single-cell genome-wide association reveals that a nonsynonymous variant in <i>ERAP1</i> confers increased susceptibility to influenza virusBenjamin H Schott, Liuyang Wang, Xinyu Zhu, et al.
Plos Pathogens|July 5, 2024
mRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNALorena C S Chaves, Nichole Orr-Burks, Daryll Vanover, et al.
Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Immunity|January 21, 2016
Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus InfectionNicholas S Heaton, Natasha Moshkina, Romain Fenouil, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Stem Cell Reports|August 19, 2022
Rapid tissue prototyping with micro-organospheresZhaohui Wang, Matteo Boretto, Rosemary Millen, et al.
Biorxiv : the Preprint Server for Biology|December 22, 2025
An integrated workflow for structural virology with a 100 keV electron microscopeRasangi Pathirage, Moumita Dutta, Ruth J Parsons, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Pageof 12